BOSTON, Nov. 13, 2024 /PRNewswire/ -- Servier today announced that it will present data at the Annual Meeting for the ...

Many individuals with sickle cell anemia undergoing controlled ovarian hyperstimulation (COH) with oocyte cryopreservation ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

Many individuals with sickle cell anemia undergoing controlled ovarian hyperstimulation (COH) with oocyte cryopreservation ...

Company to host webcast on December 9, 2024 at 8:00am ET/5:00am PTWALTHAM, Mass. and BOULDER, Colo., Nov. 05, 2024 (GLOBE ...

The FDA granted full approval to the menin inhibitor revumenib (Revuforj) for adults and children 1 year and older with relapsed/refractory acute leukemia and a lysine methyltransferase 2A gene ( ...

Research findings from Sylvester Comprehensive Cancer Center and the Miller School of Medicine at the University of Miami ...

Regeneron (REGN) Pharmaceuticals announced new and updated data from its hematology pipeline will be shared across 23 abstracts at the American Society of Hematology, ASH, 2024 Annual Meeting, taking ...

MIAMI, FLORIDA - Hematology researchers from Sylvester Comprehensive ... on more than 70 posters to be presented at the Annual Meeting & Exposition of the American Society of Hematology in San Diego, ...

Analyst Michael Ulz of Morgan Stanley reiterated a Buy rating on Silence Therapeutics (SLN – Research Report), retaining the price target ...

GSK reported positive results from its phase three ‘DREAMM-7’ trial on Thursday, highlighting a significant overall survival ...